Jaguar Health (JAGX) Debt to Equity (2014 - 2026)

Jaguar Health (JAGX) reported Debt to Equity of -$0.7 for Q1 2026, down 103.17% year-over-year from $22.2 in Q1 2025, and up 12.89% quarter-over-quarter from -$0.81 in Q4 2025.

Jaguar Health (JAGX) Debt to Equity (2014 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 13 years of Debt to Equity data on file, last reported at -$0.7 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at -$0.7, down 103.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.7 (down 103.17% YoY), and the FY2025 annual result was -$0.81, down 122.3% from the prior year.
  • Debt to Equity grew to -$0.7 in Q1 2026 per JAGX's latest filing, from -$0.81 in the prior quarter.
  • Over five years, Debt to Equity peaked at $22.2 in Q1 2025 and troughed at -$13.06 in Q4 2022.
  • A 5-year average of $4.12 and a median of $2.29 in 2023 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2022 and 2025: Debt to Equity slumped 718.5% in 2022, then surged 1108.27% in 2025.
  • A 5-year view of Debt to Equity shows it stood at -$13.06 in 2022, then surged by 148.47% to $6.33 in 2023, then sank by 42.82% to $3.62 in 2024, then tumbled by 122.3% to -$0.81 in 2025, then rose by 12.89% to -$0.7 in 2026.
  • Business Quant data shows JAGX's Debt to Equity at -$0.7 in Q1 2026, -$0.81 in Q4 2025, and $1.75 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Jaguar Health 1.44 Mn -10.19 Mn 19.11 Mn -0.70

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.70
Dec 31, 2025 -0.81
Sep 30, 2025 1.75
Jun 30, 2025 1.56
Mar 31, 2025 22.20
Dec 31, 2024 3.62
Sep 30, 2024 1.65
Jun 30, 2024 1.32
Mar 31, 2024 1.84
Dec 31, 2023 6.33
Sep 30, 2023 22.00
Jun 30, 2023 2.89
Mar 31, 2023 2.29
Dec 31, 2022 -13.06
Sep 30, 2022 5.56
Jun 30, 2022 8.48
Mar 31, 2022 3.06
Dec 31, 2021 2.11
Sep 30, 2021 1.16
Jun 30, 2021 0.76